Cargando…

Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion and prominent epidermal involvement: A case report

Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion (CMCT) is a recently described entity with only 13 cases reported in the literature. Histopathologically, the neoplasm consists of atypical epithelioid to spindled cells that form a well‐circumscribed nodule usually confined to the dermis and sub...

Descripción completa

Detalles Bibliográficos
Autores principales: Vest, Blake E., Harview, Christina L., Liu, Vincent, Swick, Brian L., Berrebi, Kristen G., Olivares, Shantel, Stone, Mary S., Sargen, Michael R., Gerami, Pedram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086857/
https://www.ncbi.nlm.nih.gov/pubmed/35751643
http://dx.doi.org/10.1111/cup.14287
_version_ 1785022234117537792
author Vest, Blake E.
Harview, Christina L.
Liu, Vincent
Swick, Brian L.
Berrebi, Kristen G.
Olivares, Shantel
Stone, Mary S.
Sargen, Michael R.
Gerami, Pedram
author_facet Vest, Blake E.
Harview, Christina L.
Liu, Vincent
Swick, Brian L.
Berrebi, Kristen G.
Olivares, Shantel
Stone, Mary S.
Sargen, Michael R.
Gerami, Pedram
author_sort Vest, Blake E.
collection PubMed
description Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion (CMCT) is a recently described entity with only 13 cases reported in the literature. Histopathologically, the neoplasm consists of atypical epithelioid to spindled cells that form a well‐circumscribed nodule usually confined to the dermis and subcutis with cytological features including large vesicular nuclei with prominent nucleoli and abundant eosinophilic cytoplasm. Immunohistochemistry shows variable expressivity of melanocytic markers. Currently, there are limited data regarding long‐term outcomes of this newly described entity. Most cases have done well, but there is one case reported with an adverse event. Hence, further studies are needed to accurately classify this tumor. Definitive diagnosis is made by laboratory evidence of CMCT. Herein, we report the first case of CMCT with epidermal involvement in the youngest patient known to be affected to date.
format Online
Article
Text
id pubmed-10086857
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Blackwell Publishing Ltd.
record_format MEDLINE/PubMed
spelling pubmed-100868572023-04-12 Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion and prominent epidermal involvement: A case report Vest, Blake E. Harview, Christina L. Liu, Vincent Swick, Brian L. Berrebi, Kristen G. Olivares, Shantel Stone, Mary S. Sargen, Michael R. Gerami, Pedram J Cutan Pathol Case Studies Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion (CMCT) is a recently described entity with only 13 cases reported in the literature. Histopathologically, the neoplasm consists of atypical epithelioid to spindled cells that form a well‐circumscribed nodule usually confined to the dermis and subcutis with cytological features including large vesicular nuclei with prominent nucleoli and abundant eosinophilic cytoplasm. Immunohistochemistry shows variable expressivity of melanocytic markers. Currently, there are limited data regarding long‐term outcomes of this newly described entity. Most cases have done well, but there is one case reported with an adverse event. Hence, further studies are needed to accurately classify this tumor. Definitive diagnosis is made by laboratory evidence of CMCT. Herein, we report the first case of CMCT with epidermal involvement in the youngest patient known to be affected to date. Blackwell Publishing Ltd. 2022-08-04 2022-12 /pmc/articles/PMC10086857/ /pubmed/35751643 http://dx.doi.org/10.1111/cup.14287 Text en © 2022 The Authors. Journal of Cutaneous Pathology published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Studies
Vest, Blake E.
Harview, Christina L.
Liu, Vincent
Swick, Brian L.
Berrebi, Kristen G.
Olivares, Shantel
Stone, Mary S.
Sargen, Michael R.
Gerami, Pedram
Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion and prominent epidermal involvement: A case report
title Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion and prominent epidermal involvement: A case report
title_full Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion and prominent epidermal involvement: A case report
title_fullStr Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion and prominent epidermal involvement: A case report
title_full_unstemmed Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion and prominent epidermal involvement: A case report
title_short Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion and prominent epidermal involvement: A case report
title_sort cutaneous melanocytic tumor with crtc1::trim11 fusion and prominent epidermal involvement: a case report
topic Case Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086857/
https://www.ncbi.nlm.nih.gov/pubmed/35751643
http://dx.doi.org/10.1111/cup.14287
work_keys_str_mv AT vestblakee cutaneousmelanocytictumorwithcrtc1trim11fusionandprominentepidermalinvolvementacasereport
AT harviewchristinal cutaneousmelanocytictumorwithcrtc1trim11fusionandprominentepidermalinvolvementacasereport
AT liuvincent cutaneousmelanocytictumorwithcrtc1trim11fusionandprominentepidermalinvolvementacasereport
AT swickbrianl cutaneousmelanocytictumorwithcrtc1trim11fusionandprominentepidermalinvolvementacasereport
AT berrebikristeng cutaneousmelanocytictumorwithcrtc1trim11fusionandprominentepidermalinvolvementacasereport
AT olivaresshantel cutaneousmelanocytictumorwithcrtc1trim11fusionandprominentepidermalinvolvementacasereport
AT stonemarys cutaneousmelanocytictumorwithcrtc1trim11fusionandprominentepidermalinvolvementacasereport
AT sargenmichaelr cutaneousmelanocytictumorwithcrtc1trim11fusionandprominentepidermalinvolvementacasereport
AT geramipedram cutaneousmelanocytictumorwithcrtc1trim11fusionandprominentepidermalinvolvementacasereport